RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

NCT06823713 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

NETWORK

Sponsor class

Conditions

End-stage Liver Disease (ESLD)
Cirrhosis, Liver
Cirrhosis, Decompensated
Liver Diseases
Fibrosis and Cirrhosis of Liver
Decompensated Liver Cirrhosis
Decompensated Cirrhosis
Steatotic Liver Disease

Interventions

DRUG: RTX001

Sponsor

Resolution Therapeutics Limited